摘要 |
<p>An industrially advantageous enteric formulation of Fluoxetin without the use of hydroxypropylmethylcellulose acetate succinate and sucrose is covered by this invention. The present invention also covers said enteric formulations of Fluoxetin in the form of tablets or capsules with an optional separating layer. When in the form of capsules, the separating layer is capsule shell itself thus reducing processing step of said enteric formulations. The formulation of the present invention along with Fluoxetin or its pharmaceutically accepted salts, solvates, enantiomers or mixtures thereof including racemic mixture is also contemplated to be within the scope of present invention.</p> |